Avanos Medical, Inc.

Avanos Medical, Inc. reported total global carbon emissions of approximately 84,021,440 kg CO2e for 2025. This includes about 1,553,080 kg CO2e from Scope 1 emissions, 4,952,360 kg CO2e from Scope 2 emissions, and 77,516,000 kg CO2e from Scope 3 emissions.

In 2024, the company's total global carbon emissions were approximately 87,648,060 kg CO2e, comprising about 1,546,985 kg CO2e from Scope 1, 12,654,080 kg CO2e from Scope 2, and 73,447,000 kg CO2e from Scope 3.

For 2023, Avanos Medical, Inc. reported total global emissions of approximately 14,457,820 kg CO2e, with Scope 1 emissions at about 1,786,730 kg CO2e and Scope 2 emissions at approximately 12,671,090 kg CO2e. Scope 3 data was not available for 2023.

The company's earlier reported global emissions include approximately 11,695,770 kg CO2e in 2021 (with Scope 1 at 229,240 kg CO2e and Scope 2 at 11,466,530 kg CO2e), 12,301,300 kg CO2e in 2020 (with Scope 1 at 218,140 kg CO2e and Scope 2 at 12,083,160 kg CO2e), and 10,010,210 kg CO2e in 2019 (with Scope 1 at 191,580 kg CO2e and Scope 2 at 9,818,630 kg CO2e). Scope 3 data was not available for these earlier years.

Avanos Medical, Inc. has not publicly disclosed specific carbon reduction targets or commitments, such as Science Based Targets Initiative (SBTi) targets or participation in The Climate Pledge. The company's performance data and climate disclosures are directly from Avanos Medical, Inc.